HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent hiccups during rehabilitation hospitalization: three case reports and review of the literature.

Abstract
Persistent hiccups have been reported to occur occasionally during rehabilitation hospitalizations. Hiccups can interfere with patient participation and progress, and this can lengthen and complicate the rehabilitation hospitalization. Chlorpromazine, the only Food and Drug Administration-approved agent specifically indicated for hiccups, is often chosen as a first-line treatment. However, chlorpromazine does not always provide favorable results. The intent of this paper is to (1) review hiccups and implications of persistent hiccups in the rehabilitation setting, (2) provide additional evidence that chlorpromazine is often not the best treatment choice for hiccups in rehabilitative patients, (3) report the effectiveness and favorable tolerability of modest doses of gabapentin in a small case series of three patients, and (4) review potentially effective treatment approaches for hiccups.
AuthorsJohn A Schuchmann, Barry A Browne
JournalAmerican journal of physical medicine & rehabilitation (Am J Phys Med Rehabil) Vol. 86 Issue 12 Pg. 1013-8 (Dec 2007) ISSN: 0894-9115 [Print] United States
PMID18090442 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Amines
  • Anti-Anxiety Agents
  • Anticonvulsants
  • Cyclohexanecarboxylic Acids
  • Dopamine Agonists
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Chlorpromazine
Topics
  • Aged
  • Amines (administration & dosage, therapeutic use)
  • Anti-Anxiety Agents (administration & dosage, therapeutic use)
  • Anticonvulsants (administration & dosage, therapeutic use)
  • Cerebral Infarction (complications)
  • Chlorpromazine (therapeutic use)
  • Chronic Disease
  • Contraindications
  • Cyclohexanecarboxylic Acids (administration & dosage, therapeutic use)
  • Diabetes Mellitus, Type 2 (complications)
  • Dopamine Agonists (therapeutic use)
  • Female
  • Gabapentin
  • Hemorrhage (complications)
  • Hiccup (diagnosis, drug therapy, etiology)
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Rehabilitation Centers
  • Risk Factors
  • Time Factors
  • gamma-Aminobutyric Acid (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: